Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 8, 2007, Pages 555-562

  Pu, Xiao Yong ^a   Wang, Xing Huan ^a   Wu, Yi Long ^a   Wang, Huai Peng ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Laparoscopy; Neoadjuvant hormonal therapy; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CATHETERIZATION; CONTROLLED STUDY; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250740939     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0204-2     Document Type: Article

References (23)

1. Brown JA, Garlitz C, Strup SE, Hubosky SG, Gomella L (2004) Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effective procedure. J Laparoendosc Adv Surg Tech A 14:335-338
2. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr (1995) Recent cancer trends in the United States. J Natl Cancer Inst 87:175-182
3. El-Feel A, Davis JW, Deger S, Roigas J, Wille AH, Schnorr D, Loening S, Hakiem AA, Tuerk IA (2003) Laparoscopic radical prostatectomy-an analysis of factors affecting operating time. Urology 62:314-318
4. Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD (1996) Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 155(1):213-219
5. Gleave ME, La Bianca SE, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD (2000) Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up. Urology 56(2):289-294
6. Gleave ME, Goldenberg SL, Chin JL, Warner J, Saad F, Klotz LH, Jewett M, Kassabian V, Chetner M, Dupont C, Van Rensselaer S, Canadian Uro-Oncology Group (2001) Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol 166:500-506
7. Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S (1996) Randomized, prospective, controlled study comparing radical prostatectomy alone versus neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol 156:873-877
8. Gregori A, Simonato A, Lissiani A, Bozzola A, Galli S, Gaboardi F (2003) Laparoscopic radical prostatectomy: perioperative complications in an initial and consecutive series of 80 cases. Eur Urol 44:190-194
9. Gu FL, Xia TL, Kong XT (1994) Peliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology 44:688-691
10. Guillonneau B, Cathelineau X, Barret E, Rozet F, Vallancien G (1998) Laparoscopic radical prostatectomy preliminary evaluation after 28 interventions. Presse Med 27(31):1570-1574
11. Klotz LH, Goldenberg SL, Jewett M, Barkin J, Chetner M, Fradet Y, Chin J, Laplante S (1999) CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group Urology 53(4):757-763
12. Macfarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrun A, deKernion JB (1993) Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol 150:132-134
13. Maldonado-Valadez R, Teber D, Erdogru T, Safi KC, Frede T, Rassweiler J (2006) The impact of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy: a matched pair analysis. J Urol 175:2092-2096
14. Meyer F, Moore L, Bairati I, Lacombe L, Tetu B, Fradet Y (1999) Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure. J Urol 162:2024-2028
15. Monfette G, Dupont A, Labrie F (1989) Early stage prostate cancer: diagnosis and choice of therapy. In: Labrie F (ed) Temporary combination therapy with flutamide and tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer. Elsevier, New York, pp 41-51
16. Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVere White R, Thompson IM Jr, Crawford ED (2002) Neoadjuvant therapy before radical prostatectomy for clinical stage T3/T4 carcinoma of the prostate: 5-year followup, phase II Southwest Oncology Group study 9109. J Urol 168:2016-2019
17. Rassweiler J, Sentker L, Seemann O, Hatzinger M, Rumpelt HJ (2001a) Laparoscopic radical prostatectomy with the Heilbronn technique: an analysis of the first 180 cases. J Urol 166:2101-2108
18. Rassweiler J, Sentker L, Seemann O, Hatzinger M, Stock C, Frede T (2001b) Heilbronn laparoscopic radical prostatectomy technique and results after 100 cases. Eur Urol 40(1):54-64
19. Rassweiler J, Seemann O, Hatzinger M, Vancaillie TG (2003) Technical evolution of laparoscopic radical prostatectomy after 450 cases. J Endourol 17:143-154
20. Schuessler WW, Kavoussi LR, Clayman RV et al (1992) Laparoscopic radical prostatectomy: initial case report. J Urol 147:246A (abstr 130)
21. Schulman CC, Debruyne FM, Forster G, Selvaggi FP, Zlotta AR, Witjes WP (2000) 4 year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3 N0M0 prostate cancer. Eur Urol 38:706-713
22. Soloway MS, Sharifi R, Wajsman Z, McLeod D, Wood DP Jr, Puras-Baez A (1995) Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol 154:424-428
23. Soloway MS, Pareek K, Sharifi R, Wajsman Z, McLeod D, Wood DP Jr, Puras-Baez A (2002) Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol 167(1):112-116